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Summary. The immunohistochemical profile of cardiac 
myxoma has been debated. The tumor is thought to be 
de r ived  f rom mul t ipo ten t i a l  und i f f e ren t i a t ed  
mesenchymal cells. A consistent marker for this tumor 
has not been found. In this article an immunohisto- 
c h e m i c a l  s tudy  of  2 3  c a r d i a c  m y x o m a s  w a s  
accompl ished.  T h i s  s tudy comprised the  immuno-  
reactivity of the tumors for thrombomodulin, calretinin 
and and c-kit (CD117). To the best of our knowledge, 
thrombomodulin and c-kit have not been tested in 
cardiac myxoma. Calretinin expression has been recently 
demonstrated in cardiac myxoma, although this finding 
has not been yet validated. Surface lining cells, tumor 
vascular endothelium, cells around the vascular slits and 
stromal cells  embedded in the myxoid matrix were  
assessed independently. All tumors showed reactivity for 
th rombomodul in  in the  s u r f a c e  c e l l s  a n d  in the  
endothelium of neoplastic vessels. 82.6% of cardiac 
myxomas expressed thrombomodulin in the stromal cells 
and  6 9 . 6 %  of the  t u m o r s  w e r e  r eac t ive  in t h e  
perivascular cells. 73.9% of cardiac myxomas expressed 
calretinin in the stromal cells and in the perivascular 
ce l l s .  Al l  m y x o m a s  w e r e  nega t ive  fo r  c-ki t .  
Thrombomodul in  and calret inin may  be impor tant  
diagnostic aids for cardiac myxoma. Cardiac myxoma 
c e l l s  d o  not e x p r e s s  e m b r y o n i c l f e t a l  endo the l i a l  
antigens. 
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Introduction 
Myxoma is the most common primary cardiac tumor 
in adults. This neoplasm may arise in any of the four 
chambers, or rarely on the valves. Cardiac myxoma is a 
benign neoplasm of controversial  histogenesis that 
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occurs  exclusively o n  the endocardial  surface.  T h e  
immunohistochemical profile of this tumor is debatable 
and of little use in the differential diagnosis (Burke and 
Virmani, 1996). Endothelial, muscle, and neural markers 
( inc luding S 1 0 0  prote in)  have been reported wi th  
variable results and marked discrepancy among authors 
(Burke and Virmani, 1996). 
In this article, a detailed evaluation of 23 cases by 
i m m u n o h i s t o c h e m i s t r y  w a s  a c c o m p l i s h e d .  T h e  
i m m u n o h i s t o c h e m i c a l  s t u d i e s  a r e  r epor t ed  us ing  
antibodies to thrombomodulin, calretinin and c-kit proto- 
o n c o g e n e  p roduc t  (CD117) .  T h r o m b o m o d u l i n ,  a 
r egu la to r  of  in t r avascu la r  c o a g u l a t i o n ,  w a s  f i rs t  
demonstrated in vascular endothelium, whereby it seems 
interesting to assess its expression in an angioformative 
tumor, like cardiac myxoma. Calretinin, a member of a 
large family of calcium binding cytoplasmic proteins, to 
which the S100 protein also belongs, has been recently 
described in cardiac myxomas in a study that has not 
been yet  va l idated  (Terraciano et  al . ,  2000) .  C-kit  
(CD117), a tyrosine kinase growth factor receptor for 
s t em ce l l  fac tor ,  i s  expressed  in embryon ic l f e t a l  
endothelium but not in adult and neovascular endothelial 
cells (Miettinen et  al., 2000). As  far a s  w e  are aware 
thrombomodulin and c-kit have not been used before in 
this tumor. The purpose of this study was to find a more 
consistent marker for cardiac myxoma. 
Materials and methods 
The study comprised 2 3  consecutive patients with 
cardiac myxomas surgically treated from 1973 until 
March 2000 at our hospital. Formaldehyde-fixed and 
paraffin-embedded blocks from 2 3  resected operative 
specimens were used for immunohistochemical study. 
For light microscopic studies, the slides were stained 
with hematoxylin-eosin. 
For  the immunohis tochemical  s tudy the 5 p m -  
sections, mounted on precoated slides, were stained by 
using the Envision+ method (Dako, Glostrup, Denmark) 
and a TechMate 500 automated immunostainer (BioTek, 
Santa Barbara, CA, USA). Diaminobenzidine (Dako) 
w a s  used  a s  a c h r o m o g e n .  To  b lock  e n d o g e n o u s  





